Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Optical coherence tomography angiography in contractile morning glory syndrome.

Cennamo G, Montorio D, Breve MA, Morra VB, Cennamo G.

Eur J Ophthalmol. 2019 Jul 17:1120672119864010. doi: 10.1177/1120672119864010. [Epub ahead of print]

PMID:
31313592
2.

Correction to: Cognitive assessment in multiple sclerosis-an Italian consensus.

Amato MP, Morra VB, Falautano M, Ghezzi A, Goretti B, Patti F, Riccardi A, Mattioli F.

Neurol Sci. 2019 May;40(5):1097. doi: 10.1007/s10072-019-03852-0.

PMID:
30900096
3.

Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey.

Lavorgna L, Esposito S, Lanzillo R, Sparaco M, Ippolito D, Cocco E, Fenu G, Borriello G, De Mercanti S, Frau J, Capuano R, Trojsi F, Rosa L, Clerico M, Laroni A, Morra VB, Tedeschi G, Bonavita S.

J Neurol. 2019 Mar;266(3):707-716. doi: 10.1007/s00415-019-09193-4. Epub 2019 Jan 16.

PMID:
30649617
4.

Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.

Pontillo G, Cocozza S, Lanzillo R, Russo C, Stasi MD, Paolella C, Vola EA, Criscuolo C, Borrelli P, Palma G, Tedeschi E, Morra VB, Elefante A, Brunetti A.

AJNR Am J Neuroradiol. 2019 Jan;40(1):99-106. doi: 10.3174/ajnr.A5915. Epub 2018 Dec 20.

PMID:
30573464
5.

Integrated Cognitive and Neuromotor Rehabilitation in Multiple Sclerosis: A Pragmatic Study.

Barbarulo AM, Lus G, Signoriello E, Trojano L, Grossi D, Esposito M, Costabile T, Lanzillo R, Saccà F, Morra VB, Conchiglia G.

Front Behav Neurosci. 2018 Sep 5;12:196. doi: 10.3389/fnbeh.2018.00196. eCollection 2018.

6.

Use of high-strength electromagnetic radiation to remove phototrophic biofilms from terracotta artifacts.

Cennamo P, Pasquino N, Guarino V, Morra V, Giorgio A, Caputo P, Moretti A.

Environ Sci Pollut Res Int. 2018 Oct;25(29):29654-29662. doi: 10.1007/s11356-018-2946-6. Epub 2018 Aug 24.

PMID:
30144008
7.

Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis.

Lavorgna L, De Stefano M, Sparaco M, Moccia M, Abbadessa G, Montella P, Buonanno D, Esposito S, Clerico M, Cenci C, Trojsi F, Lanzillo R, Rosa L, Morra VB, Ippolito D, Maniscalco G, Bisecco A, Tedeschi G, Bonavita S.

Mult Scler Relat Disord. 2018 Oct;25:175-178. doi: 10.1016/j.msard.2018.07.046. Epub 2018 Jul 31.

PMID:
30096683
8.

Gravity modeling finds a large magma body in the deep crust below the Gulf of Naples, Italy.

Fedi M, Cella F, D'Antonio M, Florio G, Paoletti V, Morra V.

Sci Rep. 2018 May 29;8(1):8229. doi: 10.1038/s41598-018-26346-z.

9.

Cognitive assessment in multiple sclerosis-an Italian consensus.

Amato MP, Morra VB, Falautano M, Ghezzi A, Goretti B, Patti F, Riccardi A, Mattioli F.

Neurol Sci. 2018 Aug;39(8):1317-1324. doi: 10.1007/s10072-018-3427-x. Epub 2018 May 15. Erratum in: Neurol Sci. 2019 May;40(5):1097.

PMID:
29766386
10.

Cerebellar lobule atrophy and disability in progressive MS.

Cocozza S, Petracca M, Mormina E, Buyukturkoglu K, Podranski K, Heinig MM, Pontillo G, Russo C, Tedeschi E, Russo CV, Costabile T, Lanzillo R, Harel A, Klineova S, Miller A, Brunetti A, Morra VB, Lublin F, Inglese M.

J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1065-1072. doi: 10.1136/jnnp-2017-316448. Epub 2017 Aug 26.

PMID:
28844067
11.

Longitudinal Assessment of Dentate Nuclei Relaxometry during Massive Gadobutrol Exposure.

Tedeschi E, Cocozza S, Borrelli P, Ugga L, Morra VB, Palma G.

Magn Reson Med Sci. 2018 Jan 10;17(1):100-104. doi: 10.2463/mrms.cr.2016-0137. Epub 2017 Mar 27.

12.

Affective disorders and Health-Related Quality of Life (HRQoL) in adolescents and young adults with Multiple Sclerosis (MS): the moderating role of resilience.

Rainone N, Chiodi A, Lanzillo R, Magri V, Napolitano A, Morra VB, Valerio P, Freda MF.

Qual Life Res. 2017 Mar;26(3):727-736. doi: 10.1007/s11136-016-1466-4. Epub 2016 Dec 7.

PMID:
27928696
13.

Effects of anthropogenic activities in a Mediterranean coastland: the case study of the Falerno-Domitio littoral in Campania, Tyrrhenian Sea (southern Italy).

Balassone G, Aiello G, Barra D, Cappelletti P, De Bonis A, Donadio C, Guida M, Melluso L, Morra V, Parisi R, Pennetta M, Siciliano A.

Mar Pollut Bull. 2016 Nov 15;112(1-2):271-290. doi: 10.1016/j.marpolbul.2016.08.004. Epub 2016 Sep 7.

PMID:
27612929
14.

Autophagosome-lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRL.

De Leo MG, Staiano L, Vicinanza M, Luciani A, Carissimo A, Mutarelli M, Di Campli A, Polishchuk E, Di Tullio G, Morra V, Levtchenko E, Oltrabella F, Starborg T, Santoro M, Di Bernardo D, Devuyst O, Lowe M, Medina DL, Ballabio A, De Matteis MA.

Nat Cell Biol. 2016 Aug;18(8):839-850. doi: 10.1038/ncb3386. Epub 2016 Jul 11.

15.

In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents.

Tedeschi E, Palma G, Canna A, Cocozza S, Russo C, Borrelli P, Lanzillo R, Angelini V, Postiglione E, Morra VB, Salvatore M, Brunetti A, Quarantelli M.

Eur Radiol. 2016 Dec;26(12):4577-4584. Epub 2016 Feb 23.

PMID:
26905870
16.

SPG5 and multiple sclerosis: clinical and genetic overlap?

Criscuolo C, Carbone R, Lieto M, Peluso S, Guacci A, Filla A, Quarantelli M, Lanzillo R, Morra VB, De Michele G.

Acta Neurol Scand. 2016 Jun;133(6):410-4. doi: 10.1111/ane.12476. Epub 2015 Sep 15.

PMID:
26370385
17.

ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism.

Panza E, Escamilla-Honrubia JM, Marco-Marín C, Gougeard N, De Michele G, Morra VB, Liguori R, Salviati L, Donati MA, Cusano R, Pippucci T, Ravazzolo R, Németh AH, Smithson S, Davies S, Hurst JA, Bordo D, Rubio V, Seri M.

Brain. 2016 Jan;139(Pt 1):e3. doi: 10.1093/brain/awv247. Epub 2015 Aug 21. No abstract available.

PMID:
26297558
18.

The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis.

Cervo A, Cocozza S, Saccà F, Giorgio SMDA, Morra VB, Tedeschi E, Marsili A, Vacca G, Palma V, Brunetti A, Quarantelli M.

Eur J Radiol. 2015 Jan;84(1):151-157. doi: 10.1016/j.ejrad.2014.10.019. Epub 2014 Nov 13.

PMID:
25466774
19.

A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2.

Saccà F, Puorro G, Brunetti A, Capasso G, Cervo A, Cocozza S, de Leva M, Marsili A, Pane C, Quarantelli M, Russo CV, Trepiccione F, De Michele G, Filla A, Morra VB.

J Neurol. 2015 Jan;262(1):149-53. doi: 10.1007/s00415-014-7551-0. Epub 2014 Oct 28.

PMID:
25346067
20.

Uric acid: a potential biomarker of multiple sclerosis and of its disability.

Moccia M, Lanzillo R, Palladino R, Russo C, Carotenuto A, Massarelli M, Vacca G, Vacchiano V, Nardone A, Triassi M, Morra VB.

Clin Chem Lab Med. 2015 Apr;53(5):753-9. doi: 10.1515/cclm-2014-0744.

PMID:
25241733
21.

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.

Laroni A, Brogi D, Morra VB, Guidi L, Pozzilli C, Comi G, Lugaresi A, Turrini R, Raimondi D, Uccelli A, Mancardi GL; EAP Investigators.

BMC Neurol. 2014 Apr 1;14:65. doi: 10.1186/1471-2377-14-65.

22.

Internal jugular vein blood flow in multiple sclerosis patients and matched controls.

Mancini M, Lanzillo R, Liuzzi R, Di Donato O, Ragucci M, Monti S, Salvatore E, Morra VB, Salvatore M.

PLoS One. 2014 Mar 27;9(3):e92730. doi: 10.1371/journal.pone.0092730. eCollection 2014.

23.

Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study.

Patti F, Morra VB, Amato MP, Trojano M, Bastianello S, Tola MR, Cottone S, Plant A, Picconi O; COGIMUS Study Group.

PLoS One. 2013 Aug 30;8(8):e74111. doi: 10.1371/journal.pone.0074111. eCollection 2013.

24.

Predictors of survival in a Huntington's disease population from southern Italy.

Rinaldi C, Salvatore E, Giordano I, De Matteis S, Tucci T, Cinzia VR, Rossi F, Castaldo I, Morra VB, Di Maio L, Filla A, De Michele G.

Can J Neurol Sci. 2012 Jan;39(1):48-51.

PMID:
22384495
25.

Multiple sclerosis: cerebral circulation time.

Mancini M, Morra VB, Di Donato O, Maglio V, Lanzillo R, Liuzzi R, Salvatore E, Brunetti A, Iaccarino V, Salvatore M.

Radiology. 2012 Mar;262(3):947-55. doi: 10.1148/radiol.11111239.

PMID:
22357894
26.

Co-existence of primary hyperparathyroidism and Parkinson's disease in three patients: an incidental finding?

De Rosa A, Rinaldi C, Tucci T, Pappatà S, Rossi F, Morra VB, Faggiano A, Colao A, De Michele G.

Parkinsonism Relat Disord. 2011 Dec;17(10):771-3. doi: 10.1016/j.parkreldis.2011.04.021. Epub 2011 Jul 5. No abstract available.

PMID:
21733736
27.

Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patients.

Lanzillo R, Di Somma C, Quarantelli M, Ventrella G, Gasperi M, Prinster A, Vacca G, Pivonello C, Orefice G, Colao A, Morra VB.

Eur J Neurol. 2011 Dec;18(12):1402-6. doi: 10.1111/j.1468-1331.2011.03433.x. Epub 2011 May 18.

PMID:
21585623
28.

KIRs and their HLA ligands in remitting-relapsing multiple sclerosis.

Fusco C, Guerini FR, Nocera G, Ventrella G, Caputo D, Valentino MA, Agliardi C, Gallotti J, Morra VB, Florio C, Clerici M, Lombardi ML.

J Neuroimmunol. 2010 Dec 15;229(1-2):232-7. doi: 10.1016/j.jneuroim.2010.08.004. Epub 2010 Sep 9.

PMID:
20826009
29.

A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosis.

Prinster A, Quarantelli M, Lanzillo R, Orefice G, Vacca G, Carotenuto B, Alfano B, Brunetti A, Morra VB, Salvatore M.

Mult Scler. 2010 Jan;16(1):45-54. doi: 10.1177/1352458509351896. Epub 2009 Dec 22.

30.

Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis.

Patti F, Amato MP, Bastianello S, Caniatti L, Di Monte E, Ferrazza P, Goretti B, Gallo P, Morra VB, Lo Fermo S, Picconi O, Tola MR, Trojano M; COGIMUS Study Group.

Mult Scler. 2010 Jan;16(1):68-77. doi: 10.1177/1352458509350309. Epub 2009 Dec 7.

PMID:
19995846
31.

Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study.

Sbardella E, Tomassini V, Gasperini C, Bellomi F, Cefaro LA, Morra VB, Antonelli G, Pozzilli C.

BMC Neurol. 2009 Oct 13;9:54. doi: 10.1186/1471-2377-9-54.

32.

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.

Salvatore E, Morra VB, Orefice G.

Neurology. 2009 Sep 29;73(13):1078; author reply 1078-9. doi: 10.1212/WNL.0b013e3181ab6e08. No abstract available.

PMID:
19786703
33.

Simultaneous determination of beta2-agonists in human urine by fast-gas chromatography/mass spectrometry: method validation and clinical application.

Di Corcia D, Morra V, Pazzi M, Vincenti M.

Biomed Chromatogr. 2010 Apr;24(4):358-66. doi: 10.1002/bmc.1300.

PMID:
19642085
34.

Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.

Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.

Mult Scler. 2009 Feb;15(2):204-11. doi: 10.1177/1352458508098270. Epub 2008 Nov 5.

PMID:
18987104
35.
36.

Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis.

Coppola G, Lanzillo R, Florio C, Orefice G, Vivo P, Ascione S, Schiavone V, Pagano A, Vacca G, De Michele G, Morra VB.

Eur J Neurol. 2006 Sep;13(9):1014-21.

PMID:
16930370
37.

Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta.

Annunziata P, Giorgio A, De Santi L, Zipoli V, Portaccio E, Amato MP, Clerici R, Scarpini E, Moscato G, Iudice A, Vacca G, Orefice G, Morra VB, Maimone D.

J Neurol Sci. 2006 May 15;244(1-2):97-102. Epub 2006 Feb 13.

PMID:
16473370
38.

Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study.

Prinster A, Quarantelli M, Orefice G, Lanzillo R, Brunetti A, Mollica C, Salvatore E, Morra VB, Coppola G, Vacca G, Alfano B, Salvatore M.

Neuroimage. 2006 Feb 1;29(3):859-67. Epub 2005 Oct 3.

PMID:
16203159
39.

Interferon-beta treatment decreases cholesterol plasma levels in multiple sclerosis patients.

Morra VB, Coppola G, Orefice G, De Michele G, Vacca G, Filla A, Bonavita V.

Neurology. 2004 Mar 9;62(5):829-30. No abstract available.

PMID:
15007146
40.

Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load.

Quarantelli M, Ciarmiello A, Morra VB, Orefice G, Larobina M, Lanzillo R, Schiavone V, Salvatore E, Alfano B, Brunetti A.

Neuroimage. 2003 Feb;18(2):360-6.

PMID:
12595189
41.

A refined physical and transcriptional map of the SPG9 locus on 10q23.3-q24.2.

Lo Nigro C, Cusano R, Scaranari M, Cinti R, Forabosco P, Morra VB, De Michele G, Santoro L, Davies S, Hurst J, Devoto M, Ravazzolo R, Seri M.

Eur J Hum Genet. 2000 Oct;8(10):777-82.

42.

Genetic mapping to 10q23.3-q24.2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy.

Seri M, Cusano R, Forabosco P, Cinti R, Caroli F, Picco P, Bini R, Morra VB, De Michele G, Lerone M, Silengo M, Pela I, Borrone C, Romeo G, Devoto M.

Am J Hum Genet. 1999 Feb;64(2):586-93.

43.

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome.

Millefiorini E, Gasperini C, Pozzilli C, D'Andrea F, Bastianello S, Trojano M, Morino S, Morra VB, Bozzao A, Calo' A, Bernini ML, Gambi D, Prencipe M.

J Neurol. 1997 Mar;244(3):153-9.

PMID:
9050955
44.

POEMS syndrome: clinical, pathological and immunological study of a case.

Orefice G, Morra VB, De Michele G, Fusco C, Borgia G, Cerini R, Barbieri F.

Neurol Res. 1994 Dec;16(6):477-80.

PMID:
7708142

Supplemental Content

Support Center